Massmutual Trust CO Fsb Amgen Inc Transaction History

Massmutual Trust CO Fsb

$3.48 Billion
Q3 2024

A detailed history of Massmutual Trust CO Fsb transactions in Amgen Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 6,901 shares of AMGN stock, worth $2.22 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,901

Previous 7,353 6.15%

Holding current value

$2.22 Million

Previous $2.3 Million 3.22%

% of portfolio

0.06%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$309.38 - $337.38 $139,839 - $152,495	-452 Reduced 6.15%	6,901 $2.22 Million
Q2 2024 Jul 02, 2024	BUY	$262.75 - $319.31 $108,778 - $132,194	414 Added 5.97%	7,353 $2.3 Million
Q1 2024 Apr 09, 2024	BUY	$268.87 - $324.56 $211,600 - $255,428	787 Added 12.79%	6,939 $1.97 Million
Q4 2023 Jan 03, 2024	BUY	$255.7 - $288.46 $92,052 - $103,845	360 Added 6.22%	6,152 $1.77 Million
Q3 2023 Oct 03, 2023	BUY	$218.65 - $271.46 $80,463 - $99,897	368 Added 6.78%	5,792 $1.56 Million
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $130,918 - $154,809	-611 Reduced 10.12%	5,424 $1.2 Million
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $53,286 - $64,947	236 Added 4.07%	6,035 $1.46 Million
Q4 2022 Jan 06, 2023	SELL	$229.03 - $291.01 $56,341 - $71,588	-246 Reduced 4.07%	5,799 $1.52 Million
Q3 2022 Oct 07, 2022	BUY	$224.46 - $253.15 $9,876 - $11,138	44 Added 0.73%	6,045 $1.36 Million
Q2 2022 Jul 07, 2022	SELL	$230.71 - $256.74 $1.2 Million - $1.34 Million	-5,211 Reduced 46.48%	6,001 $1.46 Million
Q1 2022 Apr 08, 2022	BUY	$219.27 - $242.57 $164,891 - $182,412	752 Added 7.19%	11,212 $2.71 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $85,319 - $97,640	429 Added 4.28%	10,460 $2.35 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $2.32 Million - $2.72 Million	-10,925 Reduced 52.13%	10,031 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $115,855 - $128,533	496 Added 2.42%	20,956 $5.11 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $250,092 - $291,442	-1,127 Reduced 5.22%	20,460 $5.09 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $31,807 - $37,877	147 Added 0.69%	21,587 $4.96 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $171,529 - $190,754	731 Added 3.53%	21,440 $5.45 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $441,511 - $541,795	2,232 Added 12.08%	20,709 $4.88 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $4,738 - $6,284	-26 Reduced 0.14%	18,477 $3.75 Million
Q4 2019 May 15, 2020	BUY	$189.21 - $243.2 $172,181 - $221,312	910 Added 5.17%	18,503 $4.46 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $350,831 - $420,369	2,015 Added 12.93%	17,593 $3.4 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $64,179 - $75,232	385 Added 2.53%	15,578 $2.87 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $46,483 - $52,397	257 Added 1.72%	15,193 $2.89 Billion
Q4 2018 Feb 26, 2019	BUY	$178.4 - $208.25 $70,289 - $82,050	394 Added 2.71%	14,936 $2.91 Billion
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $80,230 - $90,449	433 Added 3.07%	14,542 $3.01 Billion
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $52,803 - $59,310	318 Added 2.31%	14,109 $2.6 Billion
Q1 2018 May 21, 2018	BUY	$169.43 - $198.0 $9,318 - $10,890	55 Added 0.4%	13,791 $2.35 Billion
Q4 2017 Mar 01, 2018	BUY	$168.79 - $188.59 $2.2 Million - $2.45 Million	13,016 Added 1807.78%	13,736 $2.39 Billion
Q4 2017 Feb 21, 2018	SELL	$168.79 - $188.59 $1.68 Million - $1.88 Million	-9,953 Reduced 93.25%	720 $10.4 Million
Q3 2017 Feb 13, 2018	SELL	$167.29 - $191.0 $35,967 - $41,065	-215 Reduced 1.97%	10,673 $1.99 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	10,888	10,888 $1.88 Billion

Others Institutions Holding AMGN

# of Institutions

3,085

Shares Held

417M

Call Options Held

7.24M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.

Account

Massmutual Trust CO Fsb Amgen Inc Transaction History